发明名称 BONE DYSBOLISM DISEASE MARKER AND ITS UTILIZATION
摘要 <P>PROBLEM TO BE SOLVED: To provide a disease marker reflecting a bone dysbolism disease associated with the enhancement of the differentiation and activation of osteoclasts, a method for detecting the bone dysbolism disease by utilizing the disease marker and a method for screening a medicine useful for the improvement of the disease. <P>SOLUTION: This polynucleotide having at least continued 15 bases and/or a polynucleotide complementary to it in a base sequence of a NF-ATc isoform a gene or Chloride intracellular channel 14 gene is utilized as the disease marker of the bone dysbolism disease associated with the enhancement of the differentiation and activation of the osteoclasts. <P>COPYRIGHT: (C)2003,JPO
申请公布号 JP2003169687(A) 申请公布日期 2003.06.17
申请号 JP20020136030 申请日期 2002.05.10
申请人 TAKEYA TATSUO;SUMITOMO PHARMACEUT CO LTD 发明人 TAKEYA TATSUO;HAYASHI KOJI
分类号 G01N33/50;A61K45/00;A61P19/00;A61P19/08;C07K16/18;C12N15/09;C12Q1/02;C12Q1/68;G01N33/15;G01N33/68 主分类号 G01N33/50
代理机构 代理人
主权项
地址